“Risperidone Versus Quetiapine: Risk of Developing Metabolic Syndromes in Patients Suffering from Psychiatry Disorders of a Health Care Center”. 2020. Asian Journal of Pharmaceutical and Health Sciences 10 (3): 2309-17. https://www.ajphs.com/index.php/ajphs/article/view/602.